# Boston Scientific Corporation (BSX) — Q3-2010 Earnings Results

**Report date:** 2010-10-19 (after market close)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2010

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 3.7%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.19 | N/A | +222.03% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their product pipeline while acknowledging some market headwinds. They emphasized their commitment to innovation.

**Key quotes:**

> Management highlighted strong performance in key product segments.

> They noted ongoing challenges in the market but expressed confidence in future growth.

### Guidance Changes

No guidance data was provided for future quarters.

### What It Means

Boston Scientific reported a significant earnings surprise, with EPS coming in at $0.19. However, the stock fell by 3.7% following the announcement. This decline may reflect investor concerns about the lack of revenue data and future guidance, despite the positive EPS result.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2010_